Mariner Wealth Advisors (NYC)’s Ligand Pharmaceuticals LGND Stock Holding History

Mariner Wealth Advisors (NYC)’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$2K	Buy	+37	New	+$1.42K	﹤0.01%	645

Other funds holding LGND

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Mariner Wealth Advisors (NYC)'s LGND Position: Q1 2015 in Review

Mariner Wealth Advisors (NYC) opened a new position in Ligand Pharmaceuticals (LGND) in Q1 2015: 37 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #645 among its holdings.

187 funds tracked by Wall St. Rank hold LGND as of Q1 2015.

Mariner Wealth Advisors (NYC) held 37 shares of Ligand Pharmaceuticals worth $2K as of Q1 2015.
Ligand Pharmaceuticals was a new Mariner Wealth Advisors (NYC) position in Q1 2015.
Ligand Pharmaceuticals made up ﹤0.01% of Mariner Wealth Advisors (NYC)'s portfolio in Q1 2015, its #645 holding.
187 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2015.

Based on Mariner Wealth Advisors (NYC)'s 13F filing for Q1 2015, filed 14 May 2015.